Thorax. 2020 Nov 11:thoraxjnl-2020-216088. doi: 10.1136/thoraxjnl-2020-216088. Online ahead of print.
Various forms of diffuse parenchymal lung disease have been proposed as potential consequences of severe COVID‑19. We describe the clinical, radiological and histological findings of patients with COVID‑19-associated acute respiratory distress syndrome who later developed severe organising pneumonia including longitudinal follow-up. Our findings may have important implications for the therapeutic modalities in the late-phase of severe COVID‑19 and might partially explain why a subgroup of COVID‑19 patients benefits from systemic corticosteroids.
PMID:33177230 | PMC:PMC7661377 | DOI:10.1136/thoraxjnl-2020-216088